Pluri Inc. (PLUR) Financial Statements
Industry: Biological Products, (No Diagnostic Substances)
In fiscal 2026, Pluri reported revenue of $1.0M, down 24.0% from $1.3M the year before. Net income was -$23.8M (a -2344.6% net margin), or -$2.44 per diluted share. Gross margin was 44.6% and operating margin was -2454.5%. Operating activities generated -$19.6M of cash, leaving -$20.2M of free cash flow. At fiscal year end, Pluri held $24.9M in total assets against $47.9M in total liabilities, including $3.5M of cash and equivalents.
Open the full interactive Pluri financials → Quarterly statements, key ratios, valuation history and price charts.
Pluri Key Stats
| Share Price | $0.94 |
|---|---|
| Market Cap | $9.2M |
| Revenue YoY Growth | -23.9% |
| 52-Week Range | $0.94 – $4.52 |
| Shares Outstanding | 9.7 million (basic, 2026 Q4) |
Pluri Income Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Revenue | — | $234,000 | $287,000 | $326,000 | $1.3M | $1.0M |
| Gross Profit | — | — | $278,000 | $322,000 | $654,000 | $453,000 |
| Operating Income | -$50.6M | -$41.6M | -$27.2M | -$22.2M | -$22.2M | -$24.9M |
| Pre-Tax Income | -$49.9M | -$41.2M | -$28.3M | -$20.9M | -$23.3M | -$25.4M |
| Income Tax | — | — | — | — | -$5,000 | -$25,000 |
| Net Income | -$49.9M | -$41.2M | -$28.3M | -$20.9M | -$22.6M | -$23.8M |
| Diluted EPS | -$14.16 | -$10.24 | -$6.24 | -$3.99 | -$3.56 | -$2.44 |
Pluri Quarterly Results
| 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | |
|---|---|---|---|---|
| Revenue | $316,000 | $198,000 | $167,000 | $335,000 |
| Net Income | -$5.8M | -$6.5M | -$5.5M | -$5.9M |
| Diluted EPS | -$0.65 | -$0.71 | -$0.55 | -$0.60 |
Pluri Balance Sheet
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $31.2M | $9.8M | $5.4M | $6.8M | $5.9M | $3.5M |
| Current Assets | $67.4M | $57.7M | $41.4M | $31.1M | $22.1M | $8.7M |
| Total Assets | $93.5M | $68.1M | $50.8M | $39.5M | $38.7M | $24.9M |
| Current Liabilities | $11.5M | $6.8M | $5.6M | $4.5M | $32.3M | $32.7M |
| Total Long-Term Debt | $23.9M | $21.7M | $23.5M | $24.0M | — | — |
| Total Liabilities | $36.4M | $38.0M | $37.4M | $39.4M | $45.5M | $47.9M |
| Shareholders' Equity | $57.2M | $30.0M | $13.4M | $96,000 | -$6.8M | -$23.0M |
Pluri Cash Flow Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$30.9M | -$36.5M | -$22.9M | -$18.0M | -$18.2M | -$19.6M |
| Cash From Investing | -$7.3M | $11.8M | $9.7M | $10.6M | $8.0M | $9.9M |
| Cash From Financing | $61.4M | $7.5M | $8.0M | $8.8M | $9.5M | $7.0M |
| Free Cash Flow | -$31.3M | -$36.8M | -$23.1M | -$18.3M | -$19.8M | -$20.2M |
Figures from Pluri's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Pluri financials page for every line item.
Pluri Company Profile
| Ticker | PLUR |
|---|---|
| Exchange | Nasdaq |
| Industry | Biological Products, (No Diagnostic Substances) |
| Headquarters | Haifa |
| Incorporated in | Nevada |
| Fiscal Year End | June 30 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001158780 |
Frequently Asked Questions
What was Pluri's revenue in fiscal 2026?
Pluri (PLUR) reported revenue of $1.0M for fiscal 2026.
What is Pluri's annual revenue history?
Pluri's annual revenue by fiscal year: 2022: $234,000; 2023: $287,000; 2024: $326,000; 2025: $1.3M; 2026: $1.0M.
What was Pluri's net income in fiscal 2026?
Pluri reported net income of -$23.8M for fiscal 2026.
What was Pluri's earnings per share (EPS) in fiscal 2026?
Pluri's diluted EPS was -$2.44 for fiscal 2026 (adjusted for any later stock splits).
How much free cash flow did Pluri generate in fiscal 2026?
Pluri generated -$20.2M of free cash flow in fiscal 2026.
What was Pluri's revenue last quarter?
In its most recent reported quarter (2026 Q4), Pluri reported revenue of $335,000.
How many shares of Pluri are outstanding?
Pluri reported a weighted average of 9.7 million basic shares outstanding in 2026 Q4.
What is Pluri's market cap?
Based on its latest closing price, Pluri (PLUR) has a market capitalization of about $9.2M.
When does Pluri's fiscal year end?
Pluri's fiscal year end, as registered with the SEC, is June 30.
Where is Pluri headquartered?
Pluri lists its business address in Haifa in its SEC filings.
Pluri Competitors & Similar Companies
See all 136 Biological Products, (No Diagnostic Substances) companies →